Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 127.55 | (661.42) | (487.71)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 389.90 | (420.50) | (344.31)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
| Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
| A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
| Currency | US Dollars |
| Share Price | $ 61.73 |
| Change Today | $ -1.81 |
| % Change | -2.85 % |
| 52 Week High | $63.96 |
| 52 Week Low | $60.84 |
| Volume | 1,879,611 |
| Shares Issued | 55.37m |
| Market Cap | $3,418.18m |
| RiskGrade | 332 |
| Strong Buy | 3 |
| Buy | 13 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 20 |

| Time | Volume / Share Price |
| 15:59 | 200 @ $61.71 |
| 15:59 | 200 @ $61.71 |
| 15:59 | 100 @ $61.71 |
| 15:59 | 400 @ $61.71 |
| 15:59 | 100 @ $61.71 |
You are here: research